Bridging adults and paediatrics with secondary hyperparathyroidism receiving haemodialysis: a pharmacokinetic‐pharmacodynamic analysis of cinacalcet
Author:
Affiliation:
1. Amgen Inc. Thousand Oaks CA USA
2. SGS Exprimo London UK
Funder
Amgen
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13900
Reference51 articles.
1. Executive summary of the 2017 KDIGO Chronic Kidney Disease‐Mineral and Bone Disorder (CKD‐MBD) Guideline Update: What's changed and why it matters;Ketteler M;Kidney Int,2017
2. The consequences of uncontrolled secondary hyperparathyroidism and its treatment in chronic kidney disease;Goodman WG;Semin Dial,2004
3. Regulation of parathyroid hormone synthesis and secretion;Silver J;Semin Nephrol,1994
4. Secondary hyperparathyroidism: Pathogenesis, disease progression, and therapeutic options;Cunningham J;Clin J Am Soc Nephrol,2011
5. Coronary‐artery calcification in young adults with end‐stage renal disease who are undergoing dialysis;Goodman WG;N Engl J Med,2000
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Bayesian Complex Innovative Trial Designs (CIDs) and Their Use in Drug Development for Rare Disease;The Journal of Clinical Pharmacology;2022-12
2. Personalised medicines for familial hypercalcemia and hyperparathyroidism;Journal of Molecular Endocrinology;2022-03
3. Pharmacokinetic/pharmacodynamic data extrapolation models for improved pediatric efficacy and toxicity estimation, with application to secondary hyperparathyroidism;Pharmaceutical Statistics;2020-07-09
4. Development and Validation of Stability Indicating RP-HPLC Method for the Estimation of Cinacalcet Hydrochloride in Bulk and Their Formulations;Biointerface Research in Applied Chemistry;2020-05-27
5. Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis;Pediatric Nephrology;2020-05-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3